The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).
 
Antonio Marcilio Padula Omuro
Consulting or Advisory Role - BTG; Merck
Research Funding - Agios; Arcus Biosciences; Bristol-Myers Squibb; Inovio Pharmaceuticals; Merck; Tactical Therapeutics; Tocagen
 
Lisa Marie DeAngelis
Consulting or Advisory Role - BTG; Sapience Therapeutics
 
Theodore Karrison
No Relationships to Disclose
 
Joe A Bovi
Honoraria - Elekta
Consulting or Advisory Role - Elekta
 
Marc Rosenblum
No Relationships to Disclose
 
Benjamin W. Corn
No Relationships to Disclose
 
Denise Correa
No Relationships to Disclose
 
Jeffrey Scott Wefel
Consulting or Advisory Role - Angiochem (Inst); Bayer; Blueprint Medicines; Genentech/Roche (Inst); Juno Therapeutics (Inst); Novocure (Inst); Vanquish Oncology
 
Sanjay Aneja
Consulting or Advisory Role - Prophet Consulting (I)
Research Funding - AHRQ; American Cancer Society; National Science Foundation; theMednet
Patents, Royalties, Other Intellectual Property - Provisional patent of deep learning optimization algorithm
Travel, Accommodations, Expenses - Prophet Consulting (I); The Hope Foundation
 
Christian Grommes
Honoraria - Scripps Health
Consulting or Advisory Role - BTG; Kite/Gilead
Other Relationship - Bayer; Bristol-Myers Squibb; Celgene; Pharmacyclics
 
Lauren Schaff
Research Funding - BTG
 
Steven E. Waggoner
Consulting or Advisory Role - Regeneron
 
Enrico C. Lallana
No Relationships to Disclose
 
Maria Werner-Wasik
No Relationships to Disclose
 
Fabio Iwamoto
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Guidepoint Global; Merck; Novocure; Regeneron; Tocagen
Speakers' Bureau - Prime Oncology
Research Funding - Bristol-Myers Squibb; Celldex; FORMA Therapeutics; Merck; Northwest Biotherapeutics; Tocagen
Travel, Accommodations, Expenses - Oncoceutics
(OPTIONAL) Uncompensated Relationships - Northwest Biotherapeutics
 
Timothy J. Robinson
No Relationships to Disclose
 
Eric Donnelly
Employment - Northwestern Medicine
 
Timothy Struve
No Relationships to Disclose
 
Minhee Won
No Relationships to Disclose
 
Minesh P. Mehta
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Consulting or Advisory Role - AstraZeneca; Blue Earth Diagnostics; Karyopharm Therapeutics; Tocagen
Research Funding - Novocure (Inst)
Patents, Royalties, Other Intellectual Property - WARF patent 14/934,27, TOPICAL VASOCONSTRITOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY
(OPTIONAL) Uncompensated Relationships - Xcision Medical Systems